Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Spironolactone may help reduce hair loss in androgenic alopecia.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Finasteride helps reduce heart issues and improves heart function.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Alopecia causes significant emotional distress and psychological issues, requiring combined skin and mental health treatment.

Pregnancy can cause more body and scalp hair growth and make nails brittle, but these changes often revert after giving birth.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Moderately high prolactin levels do not cause hair loss in women.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Environmental factors like temperature and nutrition affect hair growth, with humans showing seasonal hair growth differences.

Testosterone helps human pancreatic cells increase insulin release.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.